Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Phase 1b Adaptive Androgen Deprivation Therapy Trial in Metastatic Castration Sensitive Prostate Cancer
Jingsong Zhang, Jill Gallaher, Jessica J. Cunningham, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5225-5225
Open Access | Times Cited: 10

Showing 10 citing articles:

Adaptive Treatment of Metastatic Prostate Cancer Using Generative Artificial Intelligence
Youcef Derbal
Clinical Medicine Insights Oncology (2025) Vol. 19
Open Access
EFFECT OF LONG-TERM CENTRAL BLOCKING OF HORMONE RELEASE WITH TRIPTORELIN ON OXIDATIVE STRESS MARKER ACTIVITY IN THE LIVER OF RATS
O. A. Polyviana, Ye. V. Stetsuk, V. I. Shepitko, et al.
World of Medicine and Biology (2025) Vol. 21, Iss. 91, pp. 177-177
Closed Access
Evolutionary Dynamics and Intermittent Therapy for Metastatic Cancers
Jad Chahoud, Alexander R.A. Anderson, Jingsong Zhang, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 28, pp. 4469-4471
Open Access | Times Cited: 10
Testing Adaptive Therapy Protocols Using Gemcitabine and Capecitabine in a Preclinical Model of Endocrine-Resistant Breast Cancer
Sareh Seyedi, Ruthanne Teo, Luke Foster, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 257-257
Open Access | Times Cited: 3
How We Treat Metastatic Castration-Sensitive Prostate Cancer
Filip Ionescu, Jingsong Zhang
Cancer Control (2024) Vol. 31
Open Access | Times Cited: 2
A mathematical framework for comparison of intermittent versus continuous adaptive chemotherapy dosing in cancer
Cordelia D. McGehee, Yoichiro Mori
npj Systems Biology and Applications (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Minimally sufficient experimental design using identifiability analysis
Jana L. Gevertz, Irina Kareva
npj Systems Biology and Applications (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
The prognostic value of androgen to PSA ratio in predictive modeling of prostate cancer
Tin Phan, Allison Weber, Alan H. Bryce, et al.
Medical Hypotheses (2023) Vol. 176, pp. 111084-111084
Closed Access | Times Cited: 2
Abiraterone-Docetaxel scheduling for metastatic castration-resistant prostate cancer based on evolutionary dynamics
Atefeh Deris, Mahdi Sohrabi-Haghighat
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0282646-e0282646
Open Access | Times Cited: 1
Testing Adaptive Therapy Protocols using Gemcitabine and Capecitabine on a Mouse Model of Endocrine-Resistant Breast Cancer
Sareh Seyedi, Ruthanne Teo, Luke Foster, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Minimally Sufficient Experimental Design using Identifiability Analysis
Jana L. Gevertz, Irina Kareva
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Page 1

Scroll to top